NEW YORK CITY (MedPage Today) -- Patients with borderline personality disorder showed significant improvements when treated with long-acting antipsychotic agent quetiapine fumarate (Seroquel XR). via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment